← Back to catalogue

Ria Diag. Test Kit For Indexing Thyrox.

FDA 510(k)

Class II (US FDA 510(k))

510(k) K781560

by Nuclear Diagnostics, Inc.

Identifiers

510(k) Number
K781560 FDA 510(k)
FDA Product Code
CEC FDA 510(k)

Classification

Device Class
Class II FDA 510(k)
Legislation / Framework
21 CFR Part 862.1695 FDA 510(k)
Regulation Number
862.1695 FDA 510(k)
Advisory Committee
Clinical Chemistry FDA 510(k)
FDA Decision
SESE Substantially Equivalent FDA 510(k)

This device is a radioimmunoassay (RIA) test kit for measuring free thyroxine (T4) levels in clinical chemistry. Radioimmunoassays are in vitro diagnostic tests that quantify specific substances—such as hormones—by exploiting the binding affinity between antibodies and antigens. The kit is designed to provide quantitative results for thyroid function assessment, aiding in the diagnosis and monitoring of thyroid disorders.

The RIA Diagnostic Test Kit for Indexing Thyroxine is intended for laboratory use and is supplied as a single-use diagnostic reagent. It is classified under FDA regulation 862.1695 as a Class II device, with an FDA 510(k) clearance (K781560) granted in 1978. No third-party review or additional regulatory markings (e.g., CE marking) are indicated in the available data. The kit requires proper storage and handling per manufacturer instructions to maintain accuracy and reliability.

Frequently asked questions

What is the primary clinical use of this RIA test kit, and how does it differ from other thyroid function tests?

This RIA Diagnostic Test Kit for Indexing Thyroxine is specifically designed to measure free thyroxine (T4) levels in clinical chemistry, enabling quantitative assessment of thyroid function. Unlike some tests that measure total T4 (bound and unbound), this kit focuses on free T4, which is the biologically active fraction of the hormone. This distinction helps clinicians diagnose and monitor thyroid disorders—such as hyperthyroidism or hypothyroidism—by providing precise measurements of unbound thyroxine, which is critical for accurate thyroid function evaluation.

Is this test kit intended for single-use, or can it be reused across multiple patient samples?

The kit is explicitly labeled as a single-use diagnostic reagent, meaning each kit is designed for one test cycle only. Reusing it could compromise accuracy, reliability, and sterility, which are essential for valid clinical results. Always follow the manufacturer’s instructions for proper handling and disposal to maintain test integrity.

What regulatory pathway was followed for FDA clearance, and how does this affect its use in clinical settings?

The kit received FDA 510(k) clearance (K781560) under the Traditional 510(k) pathway, with a decision of *Substantially Equivalent* (SESE) to a predicate device. This means it was determined to have the same intended use and technological characteristics as a previously cleared device, ensuring compliance with FDA standards for Class II diagnostic devices. Clinicians can rely on this clearance as evidence of the kit’s safety and effectiveness for measuring free thyroxine in laboratory settings, though adherence to manufacturer guidelines remains critical for accurate results.

Are there specific storage requirements for this test kit to ensure its accuracy and longevity?

While the exact storage conditions aren’t detailed in the provided data, all RIA test kits—including this one—typically require proper storage per manufacturer instructions to preserve sterility, stability, and performance. This usually involves refrigeration (e.g., 2–8°C) and protection from light, moisture, or extreme temperatures. Failure to store it correctly may lead to degraded reagents or inaccurate test results, so always refer to the accompanying documentation for precise guidelines.

How does the advisory committee classification (Clinical Chemistry) impact the use of this device in a lab?

The classification under the Clinical Chemistry advisory committee (CH) indicates that this kit is intended for use in specialized laboratory settings where precise hormone quantification is performed. This classification helps labs identify the appropriate workflows, quality control protocols, and training requirements for handling RIA-based assays. Clinicians should ensure their laboratory has the necessary infrastructure—such as radiochemistry expertise and proper disposal systems—to safely and accurately use this device for thyroid function assessment.

This description and any FAQs above were generated automatically from registry data and have not been verified by the manufacturer or by deviCERTS. Always check the official registry entry and the manufacturer's instructions for use before relying on them. Sources consulted: RIA DIAG. TEST KIT FOR INDEXING THYROX. 510(k) K781560 - fda.report, RIA DIAG. TEST KIT FOR INDEXING THYROX. 510(k) K781560 - fda.report, Nuclear Diagnostics, Inc. · DeviceClearance, Nuclear Diagnostics Inc FDA Filings

Authorization Coverage (1 country)

Regulatory Authorizations

United States Active

FDA_510K

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA 510(k) K781560 24 fields · synced Sep 20, 2026